GlassScriptPhysician profile
Muhammad A Mirza
NPI 1548269822
$1,416.19
in general payments reported to CMS, 2019-2025
11 companies · $57.75 in 2025
The $57.75 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.68 · 2020: $765 · 2021: $86.01 · 2022: $51.24 · 2023: $249 · 2024: $157 · 2025: $57.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $735.08 | 2020 | |
| Augmedics INC. | $197.04 | 2023-2024 | Xvision |
| Pfizer INC. | $93.03 | 2019-2025 | |
| Sanofi Pasteur INC. | $84.35 | 2021-2025 | |
| Glaxosmithkline, LLC. | $79.19 | 2019-2023 | Bexsero |
| Merck Sharp & Dohme LLC | $63.84 | 2020-2024 | Vaxelis, Gardasil, Vaxneuvance |
| Cranial Technologies, INC | $62.07 | 2021-2024 | Doc Band |
| Medtronic, INC. | $46.71 | 2024 | O-Arm |
| Alk-Abello, INC | $21.97 | 2024 | Grastek, Odactra, Ragwitek |
| Phadia US INC. | $16.48 | 2024 | Immunocap |
| Depuy Synthes Sales INC. | $16.43 | 2025 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Mirza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.